Skip to main content

Doctors are fighting brain cancer by growing mini-brains

Dissected tumor pieces that will be used to grow brain organoids.
Dissected tumor pieces that will be used to grow brain organoids. Penn Medicine

Glioblastoma is one of the most common and aggressive forms of brain cancer, and it is particularly difficult to treat. Now, researchers from the University of Pennsylvania School of Medicine have come up with a new approach to treatment for the disease, by growing organoids based on a patient’s own tumor to find the most effective treatments. Digital Trends spoke to senior author Dr. Donald O’Rourke to learn more.

The technique uses mini-brains — pea-sized organoids grown from stem cells which recreate features of full-scale brains. The mini-brains are similar enough to real brains that they can be used for testing out medical treatments to see how a full-sized brain would respond.

The breakthrough in this research is regarding treatment individualization. One of the challenges of treating a complex disease like brain cancer is that different people respond in different ways to the various treatment options available. After surgery has been performed to remove a tumor, doctors typically begin further treatment using radiation or chemotherapy around one month later. That means there isn’t always time to use perform genetic analysis to see which treatment might be best suited for a particular patient — the doctors need to know what will work and start further treatment as soon as possible.

This is where the mini-brains come in. Doctors can take stem cells from a patient’s tumor and grow them into a tumored mini-brain, within a few weeks. Then these organoids can be implanted into mouse brains, and doctors can test how they respond to different treatments. They can try things like different combinations of drugs, or a relatively new type of treatment called CAR T-cell therapy, in which a patient’s immune system cells are changed so they attack the cancer cells. They can see which treatment is most effective for particular tumors, and then apply those treatments to the patient.

One of the senior authors of the paper, Dr. Donald O’Rourke, explained to Digital Trends how the organoids are currently being used and the group’s plan for future research: “We are currently testing CAR T-cells used in our ongoing clinical trial,” he said. “We will correlate CAR T responses using brain organoids with CAR T clinical responses.” That means they will be able to get an indication of how patients respond to CAR T-cell therapy before treatment even begins.

In addition, they also want to use brain organoids to select participants for future research trials: “We envision the brain organoids as an advanced diagnostic assay which will allow real-time treatment predictions,” Dr. O’Rourke said.”In the future, when we have additional CAR T trials, we will potentially be able to evaluate preferred CAR T-cells for each tumor prior to study enrollment.” That way, they can try out new methods on those patients which the treatments are most likely to help.

The research is published in the journal Cell.

Editors' Recommendations

Georgina Torbet
Georgina is the Digital Trends space writer, covering human space exploration, planetary science, and cosmology. She…
Genetically modified chickens lay eggs containing cancer-fighting proteins
edinburgh cancer fighting eggs

You may have heard the children's story about the goose who laid the golden egg, but have you heard the very real story about the genetically modified chickens who laid the cancer-fighting eggs? This latter project is something that researchers from the U.K.’s University of Edinburgh have been working on.

After splicing a human gene into chicken DNA, the researchers found that eggs laid by the gene-edited chickens contained elevated levels of cancer-treating proteins in their egg whites. This process did not have any noticeable negative effect on the chickens. It could represent a new method of producing these valuable proteins in a manner that is up to 100 times cheaper than the current cost of producing them in a factory.

Read more
Researchers find a way to create a renewable supply of cancer-fighting T cells
cancer therapy t cell stem cells

Researchers at the University of California, Los Angeles have made a major advance in the battle against cancer by showing that it’s possible to create mature T cells with important cancer-killing receptors from pluripotent stem cells.

This was achieved by using structures called artificial thymic organoids, which mimic the environment of the thymus, referring to the organ in which T cells develop from blood stem cells.

Read more
Don’t buy the Meta Quest Pro for gaming. It’s a metaverse headset first
Meta Quest Pro enables 3D modeling in mixed reality.

Last week’s Meta Connect started off promising on the gaming front. Viewers got release dates for Iron Man VR, an upcoming Quest game that was previously a PS VR exclusive, as well as Among Us VR. Meta, which owns Facebook, also announced that it was acquiring three major VR game studios -- Armature Studio, Camouflaj Team, and Twisted Pixel -- although we don’t know what they’re working on just yet.

Unfortunately, that’s where the Meta Connect's gaming section mostly ended. Besides tiny glimpses and a look into fitness, video games were not the show's focus. Instead, CEO Mark Zuckerberg wanted to focus on what seemed to be his company’s real vision of VR's future, which involves a lot of legs and a lot of work with the Quest Pro, a mixed reality headset that'll cost a whopping $1,500.

Read more